%0 Journal Article
%T Perioperative rh-endostatin with chemotherapy improves the survival of conventional osteosarcoma patients: a prospective non-randomized controlled study
%A Hairong Xu
%A Lin Hao
%A Qing Zhang
%A Xiaohui Niu
%A Yuan Li
%A Zhen Huang
%J Archive of "Cancer Biology & Medicine".
%D 2019
%R 10.20892/j.issn.2095-3941.2018.0315
%X Anti-angiogenic drugs are an emerging treatment option against malignant tumors. The aim of this study was to determine whether the addition of perioperative rh-endostatin to chemotherapy could improve the probability of distant metastasis-free survival (DMFS) and overall survival (OS) in patients newly diagnosed with non-metastatic conventional osteosarcoma
%K Osteosarcoma
%K rh-endostatin
%K perioperative
%K distant metastasis
%K overall survival
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6528451/